Alivus Life Sciences P/B Ratio
Alivus Life Sciences (ALIVUS) P/B ratio is 3.86 (High), book value per share ₹1332.80 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Alivus Life Sciences stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ALIVUS P/B Ratio — Valuation Insights & Book Value Analysis
Alivus Life Sciences price-to-book ratio interpretation, valuation status and historical context — current P/B 3.86 (High). Compare with ALIVUS fundamental valuation to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 3.86, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 389.8% above historical average
- Trading at premium to sector average PB of -0.33
Alivus Life Sciences P/B Ratio Historical Trend
ALIVUS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Alivus Life Sciences 52-week for the annual high/low range and current price position.
ALIVUS Historical P/B Ratio — Book Value Per Share & Year-End Price
Alivus Life Sciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.8 | ₹1332.8 | ₹1070.30 | ₹3,332 | Low |
| 2025 | 0.81 | ₹1126.8 | ₹916.60 | ₹2,817 | Low |
| 2024 | 1.05 | ₹932.8 | ₹983.45 | ₹2,332 | Moderate |
| 2023 | 0.77 | ₹855.2 | ₹657.05 | ₹2,138 | Low |
| 2022 | 0.51 | ₹821.6 | ₹420.15 | ₹2,054 | Low |
ALIVUS vs Healthcare Peers — P/B Ratio Comparison
Alivus Life Sciences P/B 3.86 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |